The PR referenced in this thread is the publicatio
Post# of 148112
(Total Views: 598)
Posted On: 12/31/2020 2:36:02 PM
Re: ClosetInvestor #70634
The PR referenced in this thread is the publication of Dr. Agresti's manuscript, not the PR about FDA OLE approval. With that said, a peer reviewed publication asserting leronlimab's effectiveness in COVID certainly won't hurt our credibility with the media.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼